Clinical Trials in New York State

Showing 7501-7520 of 13,041 trials

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

NCT01232595

This study will assess the safety and efficacy of multiple daily dosing of oral LFF571 in patients who have moderate Clostridium difficile infections.

Moderate Clostridium Difficile Infection

Novartis Pharmaceuticals109 participantsStarted Oct 2010

Palm Desert, California, United States • Bristol, Connecticut, United States • Clearwater, Florida, United States +15 more locations

COMPLETEDPhase 1112 miles

Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.

NCT00532675

This study will evaluate the safety of LBH589 given in combination with lenalidomide and dexamethasone in adult patients with multiple myeloma

Multiple Myeloma

Novartis Pharmaceuticals46 participantsStarted Apr 2008

San Francisco, California, United States • Atlanta, Georgia, United States • New York, New York, United States +7 more locations

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.

Find Trials by Condition in New York State

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

Dose Finding Study for QAW039 in Asthma

Efficacy, Safety, and Pharmacokinetics of QAW039

Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)

Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer

Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Phase I/IIa Study of FIXFc in Hemophilia B Patients

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

Effect of Hepatic Impairment on LDE225..

PCA062 in pCAD-positive Tumors.

Pharmacokinetics of rFVIIIFc at Two Vial Strengths

A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors